跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Atorpel
Approved
STANDARD
Atorpel
Azarias Pharmaceutical Laboratories Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0d827ed1fe1e1b19
Company
Azarias Pharmaceutical Laboratories Inc
Type
Standard
Approval Details
Approval Id
0d827ed1fe1e1b19
Drug Approval Philippines Name
Atorpel
Product Name
Atorpel
Registration Number
DRP-6339-05
Brand Name
Atorpel
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc
Distributor
Errapel Pharmed Corp
Issuance Date
25 April 2024
Expiry Date
11 September 2025
Pharmacologic Category
HMG-CoA Reductase Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0d827ed1fe1e1b19
Type
Standard
Back to Philippines FDA Approvals
Atorpel - Philippines FDA Drug Approval Details